Sinusitis Board decisions

The appeal for service connection for a right eye disability and sleep disturbance disability was dismissed, while the appeal for a left wrist strain was denied. The 20 percent rating for a left knee disability was restored, but an increased rating was denied. No compensable ratings were granted for allergic rhinitis or prurigo nodularis.

The Board granted service connection for chronic sinusitis and a 10 percent rating for deviated septum prior to September 12, 2023, but denied a higher rating from that date.

The Board remands the matter for a new medical opinion to address inconsistencies in the Veteran's reported symptoms and service records, as well as to provide thorough medically supported rationales.

The Board granted service connection for asthma and sinusitis, effective August 10, 2022, under the provisions of the PACT Act.

The Board denied a rating in excess of 10 percent for allergic rhinitis as the evidence did not support a higher rating.

The Veteran's migraine headaches are rated at 50 percent from March 13, 2023 onward, and earlier effective dates for service connection and benefits related to allergic rhinitis, PTSD, DEA, SMC housebound, and SMC aid and attendance were granted.

The Board granted a rating of 30 percent for the right shoulder disability and 40 percent for the lower back disability, effective March 23, 2020, while denying increased ratings for other conditions.

The Board granted service connection for allergic rhinitis and denied service connection for sinusitis, both related to the Veteran's exposure to fine particulate matter during her service in Southwest Asia.

The Board granted service connection for a back disability, headache disability, sinusitis, and sleep apnea, to include as secondary to sinusitis.

The Board granted a 70 percent rating for PTSD and service connection for OSA, but remanded the issue of an increased rating for sinusitis, including a separate rating for headaches.

The Board granted service connection for sinusitis and remanded the other issues for further development.

The Board granted a 50 percent rating for migraines and service connection for vertigo, while denying increased ratings for anxiety disorder with depressive features to include TBI, chronic rhinitis, and sinusitis.

The Board granted service connection for a right shoulder condition diagnosed as bicipital tendonitis and acromioclavicular joint osteoarthritis, and an initial rating of 30 percent for sinusitis. The claims for acid reflux, hiatal hernia, and esophagitis were remanded.

The Board granted a 100 percent disability rating for somatic symptom disorder with predominant pain, persistent, and adjustment disorder with mixed disturbances of mood and conduct, and service connection for sinusitis. The claims for erectile dysfunction (ED) and special monthly compensation (SMC) based on loss of use of reproductive organ were remanded.

The Board granted service connection for chronic fatigue syndrome, dermatitis, right shoulder strain, sinusitis, and reactive airway disease. The claims for PTSD, major depressive disorder, and panic attacks were remanded.

The Veteran was granted an initial 10 percent rating for sinusitis prior to September 22, 2020, and a 30 percent rating thereafter. A 20 percent rating was also granted for hypertension throughout the period on appeal.

The Board granted service connection for sinusitis and lumbosacral strain, and a 30 percent evaluation for irritable bowel syndrome (IBS) effective May 17, 2021.

The Board granted service connection for a cervical spine disorder but denied service connection for psoriasis, varicose veins, nodule on right thyroid, sinusitis, allergic rhinitis, and gynecological disorder.

The Veteran is granted a total disability based on individual unemployability (TDIU) from January 14, 2010, and special monthly compensation (SMC) at the housebound rate from November 22, 2013.

The appeal for a rating in excess of 10 percent for allergic rhinitis was denied, and the Board remanded the issue of service connection for obstructive sleep apnea (OSA) due to insufficient evidence.